AusPAR: Bevacizumab (recombinant humanised)

Australian Public Assessment Report

AusPAR

AusPAR: Bevacizumab (recombinant humanised) [PDF, 262.73 KB]

AusPAR: Bevacizumab (recombinant humanised) [Word, 448.54 KB]

Attachment: Product Information: Bevacizumab (recombinant humanised) [PDF, 461.24 KB]

Attachment: Product Information: Bevacizumab (recombinant humanised) [Word, 600 KB]

Attachment: Extract from Clinical Evaluation Report: Bevacizumab (recombinant humanised) [PDF, 200.84 KB]

Attachment: Extract from Clinical Evaluation Report: Bevacizumab (recombinant humanised) [Word, 387.4 KB]

Device/Product Name

Avastin

Active ingredients

Bevacizumab (recombinant humanised)

AusPAR Date

7 March 2013

Published

19 July 2013

Submission Number

PM-2011-02308-3-4

Submission Type

Extension of indications

Decision

Approved